Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study

Lignende værker

• Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial
  af: Castillo, Gisell, et al.
  Udgivet: (2021)
• Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials
  af: Madison Foster, et al.
  Udgivet: (2020-10-01)
• Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials
  af: Foster, Madison, et al.
  Udgivet: (2020)
• Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis
  af: Grigor, Emma J M, et al.
  Udgivet: (2017)
• What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study
  af: Lalu, Manoj M, et al.
  Udgivet: (2020)